Logo image
Drug-induced linear IgA bullous dermatosis in a patient with a vancomycin-impregnated cement spacer
Journal article   Peer reviewed

Drug-induced linear IgA bullous dermatosis in a patient with a vancomycin-impregnated cement spacer

Kelsie Riemenschneider, Daren A Diiorio, John A Zic, Matthew R Livingood, Jo-David Fine, Jennifer G Powers, Jeffrey P Zwerner and Eric Tkaczyk
Cutis (New York, N.Y.), Vol.101(4), pp.293-296
04/2018
PMCID: PMC10183100
PMID: 29763476

View Online

Abstract

Linear IgA bullous dermatosis (LABD) is an autoimmune blistering rash caused by IgA autoantibodies against the epidermal basement membrane zone. It commonly is drug induced, often in association with systemic vancomycin. We report a case of a previously healthy 77-year-old man who developed a diffuse macular rash and hemorrhagic bullae on the left leg 10 days after placement of a vancomycin-impregnated cement spacer (VICS) during a revision knee arthroplasty and initiation of postoperative treatment with intravenous (IV) vancomycin. The lesions initially were limited to the leg in which the hardware was placed, but the patient later developed painful palmoplantar and oropharyngeal blisters as well as edematous, erythematous plaques on the back and buttocks. A punch biopsy from a lesion on the left thigh revealed neutrophil-rich subepidermal bullae, and immunofluorescence revealed linear IgA and C deposition along the dermoepidermal junction, confirming a diagnosis of LABD. This report illustrates the importance of considering antibiotic-impregnated cement spacers, which frequently are used to manage prosthetic joint infections, as potential culprits in patients with cutaneous eruptions.
Aged Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Bone Cements Humans Knee Prosthesis - adverse effects Linear IgA Bullous Dermatosis - chemically induced Male Vancomycin - administration & dosage Vancomycin - adverse effects

Details

Metrics

Logo image